ArticleJournal of medical cases2026
Trans-Endometrial Cesarean Myomectomy for a Large Anterior Lower-Segment Intramural Fibroid Preventing Hysterotomy Closure.
Article in Journal of medical cases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cesarean myomectomy has traditionally been avoided because of hemorrhage risk, but removal at cesarean delivery (CD) may be required when a fibroid distorts the lower uterine segment or prevents secure hysterotomy closure. A 35-year-old primigravida with fetal growth restriction at 38 + 2 weeks' gestation had a large anterior intramural fibroid in the lower uterine segment. Intraoperatively, the fibroid caused distortion and traction along the hysterotomy line, and prevented approximation of the myometrial edges, precluding secure closure without excision. A trans-endometrial myomectomy was performed. The lesion was enucleated using combined blunt and sharp dissection, and the myoma bed was repaired with targeted hemostatic suturing. Hemostasis was supported with continuous intravenous oxytocin infusion, followed by multilayer uterine closure. Estimated blood loss was 1,300 mL and one unit of packed red blood cells was transfused. Histopathology confirmed leiomyoma. At 6 weeks postpartum, the patient reported no secondary postpartum hemorrhage, fever, or pelvic pain, and transvaginal ultrasonography was normal. This case highlights that a trans-endometrial approach can be considered in selected situations, particularly when a large lower-segment intramural fibroid prevents secure uterine closure during CD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.